Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Demand Grows for Orthopedic Biomaterials in Europe

By HospiMedica staff writers
Posted on 25 Jul 2006
Changing demographics and lifestyle habits are increasing the incidence of typically age-related diseases, driving demand for orthopedic biomaterials across all age groups throughout Europe, according to a new report from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm.

As a result, Frost & Sullivan analyst Eleni Grammenou finds that the European orthopedic biomaterials market revenues are expected to rise from U.S.$240 million in 2005 to an estimated $609 million in 2012.

As Europe's population ages, it will be accompanied by a surge in age-related orthopedic conditions and various musculoskeletal diseases. More...
Likewise, traditionally age-related conditions such as osteoporosis and osteoarthritis will steadily increase among the younger population due to lifestyle changes such as smoking and poor nutrition, with sports and traffic-related injuries also claiming their toll on this group.

"The use of biomaterials has shown considerable clinical advantages and has been found to be particularly useful in a range of orthopedic applications including synthetic bone grafts, degradable fixation, and bone fillers,” said Mr. Grammenou. "Orthopedic biomaterials have also been found particularly useful in cranio-maxillofacial applications.”

However, the anticipated increase in demand will be challenged by cost-containment strategies affecting purchasing trends in the orthopedic braces and supports market, an alternative treatment option. In many cases, cost-cutting strategies being implemented by governments are driving hospitals to consider re-using orthopedic braces and support devices in an attempt to curb expenditures. These efforts will also affect the market for European orthopedic biomaterials.




Related Links:
Frost & Sullivan

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.